NJ A899

Establishes a three-year sickle cell disease pilot program administered by the Department of Health, with $10,200,000 appropriated from the General Fund to support grants to participating federally qualified health centers

Prioritizes federally qualified health centers in Jersey City, Newark, Paterson, Plainfield, Trenton, and Camden for program participation, with expansion to other municipalities based on demonstrated patient need and available funding

Requires participating health centers to develop comprehensive treatment programs providing coordinated medical, behavioral health, mental health, and social support services under supervision of sickle cell disease specialists

Directs the program to link outpatient and inpatient care (including telehealth), foster community outreach, promote disease education and awareness, and build a workforce of clinicians knowledgeable in sickle cell treatment

Mandates establishment of data collection practices to monitor sickle cell disease incidence, prevalence, demographics, morbidity, healthcare utilization, and costs, with unexpended funds reverting to the General Fund after program expiration